Trial Profile
A Dose Finding Study of CycloSam (153Sm-DOTMP) Combined With External Beam Radiotherapy to Treat High Risk Osteosarcoma and Other Solid Tumors Metastatic to Bone
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase I
Latest Information Update: 18 Oct 2022
Price :
$35
*
At a glance
- Drugs Samarium 153 DOTMP (Primary) ; Calcium carbonate; Filgrastim; Plerixafor
- Indications Bone metastases; Osteosarcoma; Solid tumours
- Focus Adverse reactions
- 13 Oct 2022 Status changed from suspended to withdrawn prior to enrolment.
- 03 Jun 2022 Status changed from not yet recruiting to suspended.
- 03 Dec 2021 Planned initiation date changed from 1 Nov 2021 to 1 Apr 2022.